Biovista President Dr. Aris Persidis will be presenting at the 3rd Annual Drug repositioning, rescue and repurposing conference to be held July 15-16 in Boston MA. This conference will highlight the latest developments in the fields of drug repositioning, repurposing and rescue. This conference will cover cover therapy development with the involvement of patient advocacy efforts … Read More
News
What Role for Systematic Drug Repositioning?
In an ideal world we shouldn’t need drug repositioning. In an ideal world we would know exactly how drugs work, we would have precision medicine and no need to find alternative indications. But we don’t live in an ideal world, not even an almost ideal one. And so for now, there seems to be a role for drug repositioning and even more so for systematic drug repositioning (SDR). But is SDR currently done in the best possible way? What about the art of SDR -how can we integrate SDR within an organization with minimum disruption to existing processes? And could SDR evolve to become a systematic discovery tool?
Scientists Find New Uses for Old Drugs
Interview Of Biovista’s President Aris Persidis in Voice Of America by Jessica Berman; Monday, December 10, 2013 Here is an excerpt… “It is a very easy way to explore whether something that is therapeutically beneficial in one area and for one type of patient might be useful for another type of patient,” said Aris … Read More
Repositioning Gains Momentum in Biopharma Partnerships
Article by Marie Powers in BioWorld; Monday, June 10, 2013 Article summary: Chronic fatigue syndrome (CFS) has been at the center of a vortex of controversy since the FDA handed down a complete response letter on the Toll-like receptor 3 modulator Ampligen (rintatolimod) from Hemispherx Bioscience Inc. – the only drug in development for CFS … Read More
Biovista President to present at the NYBA 2013 Annual Meeting
Biovista President Dr. Aris Persidis will be presenting at the New York Biotechnology Association 2013 Annual meeting. Dr Persidis will be presenting at the “Patient Perspectives: Seeking Cures, Not Just Returns” session and discuss Biovista’s work to date with Patient Advocacy Groups. According to the organizers “patient groups and disease foundations, no longer content to … Read More